In this webinar from March 21, 2017, Dr. Brad Brimhall discusses the Protecting Access to Medicare Act of 2014 (PAMA), its likely effect on laboratories, and the long term effects in regard to emerging value-based purchasing payment systems such as MACRA and VBP. Dr. Brimhall covers the importance of having an accurate lab cost analysis, defines cost accounting terms, and shares a cost comparison of top laboratory tests and expected PAMA reimbursements.
Webinar Learning Objectives
Following the webinar, participants will be able to:
1. Define the PAMA Final Rule and its potential effect on laboratories.
2. Evaluate PAMA’s impact in relationship to other value-based payment systems (e.g., MACRA, VBP, etc.).
3. Formulate an understanding of cost accounting and cost categories and their renewed importance in light of PAMA.
4. Evaluate results of laboratory cost analyses for many of the top lab tests in comparison to potential PAMA reimbursement values.
About Dr. Brimhall
Dr. Brimhall is a Clinical Professor of Pathology, Staff Pathologist, and Medical Director of Integrated Healthcare Analytics and Bioinformatics in the Department of Pathology at the University of Texas Health Science Center in San Antonio. He is an expert in medical analytics and data warehousing. His primary interest is in integrated medical analytics, leveraging data warehousing, big data, statistics, etc., to merge clinical diagnostic data from pathology, laboratory medicine, and other clinical areas with detailed operational and financial data to make the most cost-effective and patient-focused use of diagnostic information.
Dr. Brimhall received his medical degree from Stanford University School of Medicine. He completed his residency in Anatomic and Clinical Pathology at Brigham and Women’s Hospital and Harvard Medical School, and also holds a Master of Public Health (MPH) degree in Healthcare Policy and Management from the Harvard School of Public Health. In addition, Dr. Brimhall is board certified in Anatomic and Clinical Pathology as well as Clinical Informatics.
Orchard is committed to keeping you informed and being a trusted resource that you can turn to for industry-related education. As always, we welcome your feedback. Follow us on Twitter at @orchardsoftware, and feel free to respond to this post by emailing us at news@orchardsoft.
Kim Futrell, BS, MT(ASCP)
Products Marketing Manager
Orchard Software Corporation